منابع مشابه
Sodium valproate syrup, Sodium valproate syrup India, Sodium valproate syrup manufacturers India
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this Report is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your ...
متن کاملSodium valproate and pregnancy.
Correspondence Sodium valproate and pregnancy Sir, We were presented with a baby born to a mother taking sodium valproate who wished to breast feed. There are no data on breast milk levels of sodium valproate; it is presumed from collateral evidence that some of the drug would pass across from maternal serum into the milk. Studies in animals given modest doses of sodium valproate during pregnan...
متن کاملLevetiracetam vs sodium valproate
2011;76;383 Neurology R. Shallcross, R.L. Bromley, B. Irwin, et al. sodium valproate Child development following in utero exposure : Levetiracetam vs May 5, 2011 This information is current as of http://www.neurology.org/content/76/4/383.full.html located on the World Wide Web at: The online version of this article, along with updated information and services, is rights reserved. Print ISSN: 00...
متن کاملFrequency of Sodium Valproate-Induced Hair Loss and Curly Hair
Sodium valproate has been widely used by man as an antiepileptic drug. Hair loss and curly hair is a rare side effect of sodium valproate. We have conducted a prospective clinical study in the Department of Neurology in Shafa Hospital, Kerman, Iran for ten years (1994-2004). All 211 epileptic patients in our study were given sodium valproate as a single drug treatment. During the course of ther...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1976
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.1.6003.221-c